Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biotech VC Funding Rises As Fewer Companies Get More Dollars

Related Content

J&J enters deal with Second Genome to study gut bacteria

Jun 06 2013

BioNotebook: Second Genome/Pfizer, Merck/Agenus, Endo/Somar, Parion/Gilead, Lightstone Ventures, Kite Pharma, five IPO updates

May 05 2014

Allergan buys chin fat firm Kythera for $2.1bn

Jun 18 2015

Biotech benefits as VC firms raise cash in Q2

Jul 11 2015

Flexus flips IDO inhibitors to Bristol-Myers for up to $1.25bn

Feb 24 2015

VCs Raise Cash For New Deals; Five Biotechs Find Funding

Apr 13 2016

Related Companies

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Novartis AG

City of Hope

City of Hope

Second Genome, Inc.

Mayo Clinic

Pfizer Inc.

Johnson & Johnson

Kythera Biopharmaceuticals, Inc.

Allergan plc

Enterome SA

Nestle Health Science

Vertex Pharmaceuticals Incorporated

Sirnaomics, Inc.

Additional Topics

Companies Business Strategies Research & Development

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window